Tinavi Medical Technologies Co., Ltd.SSE: 688277

Report for Q3 2025

Oct 30, 2025 · Issued by Tinavi Medical Technologies Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 30, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-792

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Tinavi Medical Technologies Co., Ltd. on 6ix

Earlier from Tinavi Medical Technologies

Announcement on Vesting Results and Share Listing in the 2nd Vesting Period of Those Initially Granted and Those Reserved for Grant in 2023 Restricted Stock Incentive PlanOct 22, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Oct 17, 2025
Announcement on the Change of DirectorSep 27, 2025
IMPLANET Signs Exclusive Distribution Agreement with TINAVI Medical Technologies for the TiRobot® Spine Surgery SystemSep 23, 2025
Announcement on Result of Shareholding Reduction by ShareholderSep 12, 2025

Later from Tinavi Medical Technologies

Announcement on Convening the Q3 2025 Performance BriefingNov 12, 2025
Announcement on Joint Investment with Related PartiesNov 29, 2025
Announcement on Resolutions of the 26th Meeting of the 6th Board of DirectorsDec 13, 2025
Announcement on Return of Raised Funds Temporarily Used to Supplement Current CapitalDec 24, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025Dec 31, 2025

All Tinavi Medical Technologies news releases

Follow Tinavi Medical Technologies into a list and get an email when it puts out news.

Follow Tinavi Medical Technologies